ClinicalTrials.Veeva

Menu

Long Term Outcomes After Laparoscopic Intersphincteric Resection With Total Mesorectal Excision for Low Rectal Cancer. (ISR-TME)

M

Mansoura University

Status and phase

Unknown
Phase 2

Conditions

Low Rectal Cancer

Treatments

Procedure: open intersphincteric resection
Procedure: laparoscopic intersphincteric resection

Study type

Interventional

Funder types

Other

Identifiers

NCT02468362
ISR-TME

Details and patient eligibility

About

Through a double blinded study, patients with low rectal cancer will be randomized into two equal groups to compare between the 5 year disease free survival as a primary outcome measure.

Enrollment

112 estimated patients

Sex

All

Ages

18 to 80 years old

Volunteers

No Healthy Volunteers

Inclusion criteria

  • Low rectal cancer below 5 cm from the anal verge
  • Fit for laparoscopic total mesorectal excsion
  • T2, T3 rectal cancer
  • No distant metstasis

Exclusion criteria

  • T1, AND T4
  • Distant metastasis
  • Tumor infiltrating the dentate line
  • unwilling to participate

Trial design

Primary purpose

Treatment

Allocation

Randomized

Interventional model

Parallel Assignment

Masking

Double Blind

112 participants in 2 patient groups

Laparoscopic group
Active Comparator group
Treatment:
Procedure: laparoscopic intersphincteric resection
Open group
Active Comparator group
Treatment:
Procedure: open intersphincteric resection

Trial contacts and locations

0

Loading...

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems